View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
July 26, 2022

Magazine: Genomic projects exploit scale as clinical applications play catch-up

In this issue, we take a look at the potential clinical impact of genomic projects, how clinical trials can better measure pain, the evolution of the US Food and Drug Administration’s Orphan Drug program, and more.

By Manasi Vaidya

The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. Scientists are not just studying specific mutations associated with medical conditions, but also establishing frameworks to understand the role of chromosomal instability and copy number changes in driving those disorders.

This month, we take a look at emerging research in this area, including that from the United Kingdom’s 100,000 Genomes Project, and understand how clinical applications could follow in the near future.

Also in this issue, a feature takes a look at how clinical trials measure pain, the challenges of developing drugs for neglected tropical diseases, and whether Russia’s domestic pharma capabilities may shield the country from the negative effects of the sanctions imposed on it following the war in Ukraine.

Don’t miss the data-led features on hiring trends for Internet-of-Things and digitalization-related jobs in the pharma industry.

Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a new issue is available.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology